FDA OKs an eighth use for JNJ’s Xarelto
Roche’s Rituxan shows superiority in autoimmune skin condition
Sun Pharma launches dry eye disease treatment in US
Galera eyes an $86M IPO
*please scroll down for all the latest news*
Want to stay updated on CP happenings? New features, new boards, CP wire articles, and more? Click here to subscribe
